Commentary: Private-equity interest rebounding in biotech

06/5/2007 | Chicago Tribune (tiered subscription model)

Private-equity firms are beginning to show interest in biotech startups due to several market factors, including the increase in acquisitions of more mature firms, rising profits and a strong sector outlook. Investment may pick up if a trend in low returns for biotech IPOs shifts, as expected by some observers.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA